Articles

GVOKE will be the first prefilled, injectable glucagon on the market.

The company also will offer a $99 monthly subscription for up to three vials or two packs of any combination of Novo Nordisk’s analog insulins.

JDRF Announces the Creation of its First Center for Excellence

The inaugural Northern California Center for Excellence will bring together key diabetes researchers investigators involved in diabetes cellular therapy and immune system research from Stanford University and UCSF.

Insulin Pumps for Beginners

Insulin Pumps for Beginners

An overview of insulin pump therapy, with Diabetes Care and Education Specialist Ashlee Ernst.

Semma Therapeutics, Which is Developing Beta Cell Replacement Therapy, to Be Purchased for $950 Million

Vertex Pharmaceuticals announced it will acquire the company, which is developing this innovative cellular therapy to treat type 1 diabetes.

New Study Finds Autism Not More Common Among Those with Type 1 Diabetes

In the study, the researchers also found that youth with autism spectrum disorder (ASD) and type 1 diabetes had a slightly lower HbA1c than those with type 1 diabetes who did not have an ASD diagnosis.

Fiasp Approved for Children with Type 1 Diabetes in Europe

Novo Nordisk, the makers of Fiasp, has also asked the FDA to approve pediatric use of the insulin.

Word Choice Matters in Diabetes Care

In a recent webinar, a T1D Exchange diabetes researcher and an Ohio University associate professor presented the clinical impact of diabetes stigma, and how health care professionals can use person-first language to foster a collaborative conversation with people with diabetes.

A Northern Arizona University Researcher is Working to Extend Shelf Life of Insulin

Gerrick Lindberg, PhD, is testing experimental solutions to create an insulin formulation that would not need refrigeration over a long-term period.

Preprandial Insulin and Routine Eating Patterns May Help Children with Type 1 Diabetes Reach Glycemic Targets

In the Australian study, researchers found that regular mealtimes and less snacking was associated with lower HbA1c.